Novo Industri AS–1981 Harvard Case Solution & Analysis

This small but growing Danish biochemical company must choose between several financing options, including convertible Eurobonds, the right to place in Denmark and the issue of new ordinary shares in the United States. The case includes a wide range of issues concerning the ability of multinational companies to reduce the cost of capital, referring to the various capital markets around the world. "Hide
on W. Carl Kester Source: Harvard Business School 12 pages. Publication Date: February 18, 1986. Prod. #: 286084-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.